ret-avit gel 0.05 %
cts chemical industries ltd, israel - tretinoin - gel - tretinoin 0.05 %w/w - tretinoin - tretinoin - treatment acne vulgaris.
ret-avit cream 0.05 %
cts chemical industries ltd, israel - tretinoin - cream - tretinoin 0.05 %w/w - tretinoin - tretinoin - acne vulgaris.
ret-avit cream 0.025 %
cts chemical industries ltd, israel - tretinoin - cream - tretinoin 0.025 %w/w - tretinoin - tretinoin - treatment of acne vulgaris.
ret-avit gel 0.025 %
cts chemical industries ltd, israel - tretinoin - gel - tretinoin 0.025 %w/w - tretinoin - tretinoin - treatment of acne vulgaris.
aknemycin plus
neopharm ltd - erythromycin; tretinoin - solution - erythromycin 4 g / 100 g; tretinoin 0.025 g / 100 g - erythromycin, combinations - erythromycin, combinations - all forms of acne, both non-inflammatory forms with comedones and inflammatory forms with papules and pustules, particularly in the case of fat-rich skin.
audavate 0.1% cream
accord-uk ltd - betamethasone valerate - cutaneous cream - 1mg/1gram
glivec film coated tablet 100mg
novartis (singapore) pte ltd - imatinib mesylate 119.5 mg eqv imatinib base - tablet, film coated - 100 mg - imatinib mesylate 119.5 mg eqv imatinib base 100 mg
glivec film coated tablet 400mg
novartis (singapore) pte ltd - imatinib mesylate eqv imatinib base - tablet, film coated - 478.00 mg eqv. 400mg imatinib base - imatinib mesylate eqv imatinib base 400 mg
intrinsa
warner chilcott uk ltd. - testosterone - sexual dysfunctions, psychological - sex hormones and modulators of the genital system, - intrinsa is indicated for the treatment of hypoactive sexual desire disorder (hsdd) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy.
livensa
warner chilcott deutschland gmbh - testosterone - sexual dysfunctions, psychological - sex hormones and modulators of the genital system, - livensa is indicated for the treatment of hypoactive sexual desire disorder (hsdd) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy.